Cancellation of state registration. Famotidine-Acry®

February 08, 2018
Active substances:
ICD-10:
IV.E15-E16.E16.8    Other specified disorders of internal secretion of the pancreas
X.J95-J99.J95.4    Mendelssohn syndrome
XI.K20-K31.K20    Esophagitis
XI.K20-K31.K21.0    Gastroesophageal reflux with esophagitis
XI.K20-K31.K25    Stomach ulcer
XI.K20-K31.K25.0    Gastric ulcer acute with bleeding
XI.K20-K31.K26    Duodenal ulcer
XI.K20-K31.K26.0    Duodenal ulcer acute with bleeding
XI.K20-K31.K29    Gastritis and duodenitis
XI.K20-K31.K30    Dyspepsia
Famotidine-acry, famotidine, anti-ulcer drug, treatment of gastric ulcer, treatment of duodenal ulcer, dyspepsia, esophagitis, gastroesophageal reflux

The Ministry of Health of the Russian Federation, in accordance with Article 32 of Federal Law No. 61-FZ of 12.04.2010 "On the circulation of medicinal products", decided to abolish state registration and exclude from the state register of medicinal products for medical use of the medicinal product (registration certificate P N001957 / 01 from 11.08.2008 issued by OJSC "Chemical-Pharmaceutical Plant" Akrihin ", Russia):

Famotidine-Acry® (trade name of the medicinal product)

Famotidine (international non-proprietary or chemical name of the medicinal product)

film-coated tablets, 20 mg (dosage form, dosage)

JSC "Chemical-Pharmaceutical Plant" Akrihin ", Russia 142450, Moscow Region, Noginsk District, Old Kupavna, st. Kirova, 29 (name and address of the location of the manufacturer of the medicinal product)

on the basis of filing by the owner of the registration certificate of OAO Chemical-Pharmaceutical Plant (Akrihin, Russia, a statement on the cancellation of the state registration of a medicinal product.